DE1252898B
(de)
|
1965-06-12 |
1967-10-26 |
Bayer Ag |
Verfahren zur Herstellung von Copolymerisaten des Trioxans
|
US5240928A
(en)
|
1989-07-03 |
1993-08-31 |
Merck & Co., Inc. |
Substituted quinazolinones as angiotensin II antagonists
|
DE3930262A1
(de)
|
1989-09-11 |
1991-03-21 |
Thomae Gmbh Dr K |
Kondensierte diazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
|
KR910009330B1
(ko)
|
1989-10-23 |
1991-11-11 |
재단법인 한국화학연구소 |
항균작용을 갖는 퀴놀린계 화합물과 그의 제조방법
|
CA2037630C
(en)
|
1990-03-07 |
2001-07-03 |
Akira Morimoto |
Nitrogen-containing heterocylic compounds, their production and use
|
US5470975A
(en)
|
1990-10-16 |
1995-11-28 |
E.R. Squibb & Sons, Inc. |
Dihydropyrimidine derivatives
|
US5290780A
(en)
|
1991-01-30 |
1994-03-01 |
American Cyanamid Co. |
Angiotensin II receptor blocking 2,3,6 substituted quinazolinones
|
US5238942A
(en)
|
1991-05-10 |
1993-08-24 |
Merck & Co., Inc. |
Substituted quinazolinones bearing acidic functional groups as angiotensin ii antagonists
|
DE4121214A1
(de)
|
1991-06-27 |
1993-01-14 |
Bayer Ag |
7-azaisoindolinyl-chinolon- und -naphthyridoncarbonsaeure-derivate
|
US5202322A
(en)
|
1991-09-25 |
1993-04-13 |
Merck & Co., Inc. |
Quinazolinone and pyridopyrimidine a-II antagonists
|
US5532243A
(en)
|
1992-02-14 |
1996-07-02 |
The Dupont Merck Pharmaceutical Company |
Antipsychotic nitrogen-containing bicyclic compounds
|
US5358951A
(en)
|
1993-04-23 |
1994-10-25 |
American Cyanamid Company |
Angiotensin II receptor blocking 2, 3, 6 substituted quinazolinones
|
DE4407047A1
(de)
|
1994-03-03 |
1995-09-07 |
Merck Patent Gmbh |
Acetamide
|
US20010016657A1
(en)
|
1997-03-18 |
2001-08-23 |
Smithkline Beecham P.L.C. |
Substituted isoquinoline derivatives and their use as anticonvulsants
|
EE200000458A
(et)
|
1998-02-04 |
2002-02-15 |
Banyu Pharmaceutical Co., Ltd. |
Tsüklilise amiini N-atsüülderivaadid
|
JP2001039950A
(ja)
|
1999-07-30 |
2001-02-13 |
Banyu Pharmaceut Co Ltd |
N−アシル環状アミン誘導体
|
CA2389034A1
(en)
|
1999-10-27 |
2001-05-03 |
Cor Therapeutics, Inc. |
Pyridyl-containing spirocyclic compounds as inhibitors of fibrinogen-dependent platelet aggregation
|
JP2004529113A
(ja)
|
2001-03-07 |
2004-09-24 |
ファイザー・プロダクツ・インク |
ケモカイン受容体活性のモジュレーター
|
JP4459629B2
(ja)
|
2002-04-12 |
2010-04-28 |
メルク エンド カムパニー インコーポレーテッド |
二環式アミド
|
GB0303852D0
(en)
|
2003-02-19 |
2003-03-26 |
Pfizer Ltd |
Triazole compounds useful in therapy
|
WO2005023762A1
(en)
|
2003-09-04 |
2005-03-17 |
Abbott Laboratories |
Pyrrolidine-2-carbonitrile derivatives and their use as inhibitors of dipeptidyl peptidase-iv (dpp-iv)
|
SE0302811D0
(sv)
|
2003-10-23 |
2003-10-23 |
Astrazeneca Ab |
Novel compounds
|
GB0324790D0
(en)
|
2003-10-24 |
2003-11-26 |
Astrazeneca Ab |
Amide derivatives
|
US7226951B2
(en)
|
2003-12-17 |
2007-06-05 |
Allergan, Inc. |
Compounds having selective cytochrome P450RAI-1 or selective cytochrome P450RAI-2 inhibitory activity and methods of obtaining the same
|
KR100610731B1
(ko)
|
2004-02-24 |
2006-08-09 |
한국과학기술연구원 |
T-형 칼슘 채널 차단제로서 유용한 3,4-디히드로퀴나졸린유도체 및 그의 제조 방법
|
EP1720545B1
(en)
|
2004-03-03 |
2014-10-29 |
ChemoCentryx, Inc. |
Bicyclic and bridged nitrogen heterocycles
|
AU2005251891A1
(en)
|
2004-06-09 |
2005-12-22 |
F. Hoffmann-La Roche Ag |
Octahydro-pyrrolo[3,4-C] derivatives and their use as antiviral compounds
|
US7923554B2
(en)
|
2004-08-10 |
2011-04-12 |
Janssen Pharmaceutica N.V. |
HIV inhibiting 1,2,4-triazin-6-one derivatives
|
US7410949B2
(en)
|
2005-01-18 |
2008-08-12 |
Hoffmann-La Roche Inc. |
Neuropeptide-2 receptor (Y-2R) agonists and uses thereof
|
GB0504019D0
(en)
|
2005-02-26 |
2005-04-06 |
Astrazeneca Ab |
Amide derivatives
|
MX2007013469A
(es)
|
2005-04-28 |
2008-01-22 |
Wyeth Corp |
Forma ii polimorfa de tanaproget.
|
US7737279B2
(en)
|
2005-05-10 |
2010-06-15 |
Bristol-Myers Squibb Company |
1,6-dihydro-1,3,5,6-tetraaza-as-indacene based tricyclic compounds and pharmaceutical compositions comprising same
|
TW200800999A
(en)
|
2005-09-06 |
2008-01-01 |
Astrazeneca Ab |
Novel compounds
|
EP1942108B1
(en)
|
2005-10-28 |
2013-09-04 |
Ono Pharmaceutical Co., Ltd. |
Compound containing basic group and use thereof
|
JP5217438B2
(ja)
|
2005-11-18 |
2013-06-19 |
小野薬品工業株式会社 |
塩基性基を含有する化合物およびその用途
|
JP2007176809A
(ja)
|
2005-12-27 |
2007-07-12 |
Hideaki Natsukari |
複素環置換アミド化合物、その製造法および医薬組成物
|
WO2007103719A2
(en)
|
2006-03-03 |
2007-09-13 |
Incyte Corporation |
MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME
|
JP2008001743A
(ja)
|
2006-06-20 |
2008-01-10 |
Bridgestone Corp |
トレッド用ゴム組成物及びそれを用いたタイヤ
|
JP2008031064A
(ja)
|
2006-07-27 |
2008-02-14 |
Astellas Pharma Inc |
ジアシルピペラジン誘導体
|
US7820649B2
(en)
|
2006-09-11 |
2010-10-26 |
N.V. Organon |
Quinazolinone and isoquinolinone acetamide derivatives
|
AR062790A1
(es)
|
2006-09-15 |
2008-12-03 |
Schering Corp |
Derivados de azetidina utiles en el tratamiento del dolor, diabetes y trastornos del metabolismo de los lipidos
|
US8735411B2
(en)
|
2006-10-02 |
2014-05-27 |
Abbvie Inc. |
Macrocyclic benzofused pyrimidine derivatives
|
TWI405763B
(zh)
*
|
2006-11-02 |
2013-08-21 |
Targacept Inc |
菸鹼乙醯膽鹼受體亞型選擇性之二氮雜雙環烷類醯胺
|
CA2669884A1
(en)
|
2006-11-15 |
2008-05-22 |
High Point Pharmaceuticals, Llc |
Novel 2-(2-hydroxyphenyl)benzimidazoles useful for treating obesity and diabetes
|
TW200831085A
(en)
|
2006-12-13 |
2008-08-01 |
Merck & Co Inc |
Non-nucleoside reverse transcriptase inhibitors
|
EP1975165A1
(de)
|
2007-03-27 |
2008-10-01 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Substituierte Pyrrolidinamide, deren Herstellung und deren Verwendung als Arzneimittel
|
EP2142520A1
(en)
|
2007-03-29 |
2010-01-13 |
F. Hoffmann-Roche AG |
Non-nucleoside reverse transcriptase inhibitors
|
CL2008001002A1
(es)
|
2007-04-11 |
2008-10-17 |
Actelion Pharmaceuticals Ltd |
Compuestos derivados de oxazolidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion bacteriana.
|
JP2010524987A
(ja)
|
2007-04-27 |
2010-07-22 |
サノフィ−アベンティス |
2−ヘテロアリール−ピロロ[3,4−c]ピロール誘導体及びscd阻害剤としてのそれらの使用
|
JP5501230B2
(ja)
*
|
2007-08-07 |
2014-05-21 |
アボット ゲーエムベーハー ウント カンパニー カーゲー |
セロトニン5−ht6受容体の調節に応答する障害の治療に好適なキノリン化合物
|
DE102007047737A1
(de)
|
2007-10-05 |
2009-04-30 |
Merck Patent Gmbh |
Piperidin- und Piperazinderivate
|
ES2630406T3
(es)
|
2007-10-19 |
2017-08-21 |
Sarcode Bioscience Inc. |
Composición y procedimientos para el tratamiento de la retinopatía diabética
|
PE20091017A1
(es)
|
2007-10-31 |
2009-07-16 |
Janssen Pharmaceutica Nv |
Diaminas en puente o fusionadas sustituidas con arilo como moduladores de leucotrieno a4 hidrolasa
|
JP2009161449A
(ja)
|
2007-12-28 |
2009-07-23 |
Lion Corp |
Ppar活性促進剤並びに美容用飲食品、皮膚外用剤及び医薬
|
JPWO2009154132A1
(ja)
|
2008-06-19 |
2011-12-01 |
Msd株式会社 |
スピロジアミン−ジアリールケトオキシム誘導体
|
EP2328898B1
(de)
*
|
2008-09-09 |
2014-12-24 |
Sanofi |
2-heteroaryl-pyrrolo[3,4-c]pyrrol- derivate und ihre verwendung als scd inhibitoren
|
TW201020247A
(en)
|
2008-11-06 |
2010-06-01 |
Gruenenthal Gmbh |
Substituierte disulfonamide
|
US8188090B2
(en)
|
2008-11-17 |
2012-05-29 |
Hoffman-La Roche Inc. |
Naphthylacetic acids
|
DE102008059578A1
(de)
|
2008-11-28 |
2010-06-10 |
Merck Patent Gmbh |
Benzo-Naphtyridin Verbindungen
|
ES2407852T3
(es)
|
2008-12-01 |
2013-06-14 |
Merck Patent Gmbh |
Pirido[4,3-d]pirimidinas 2,5-diamino sustituidas como inhibidores de autotaxina frente al cáncer
|
TW201035102A
(en)
|
2009-03-04 |
2010-10-01 |
Gruenethal Gmbh |
Sulfonylated tetrahydroazolopyrazines and their use as medicinal products
|
WO2010101164A1
(ja)
|
2009-03-05 |
2010-09-10 |
第一三共株式会社 |
ピリジン誘導体
|
WO2010108268A1
(en)
|
2009-03-23 |
2010-09-30 |
Merck Frosst Canada Ltd. |
Heterocyclic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
|
TW201038572A
(en)
|
2009-03-25 |
2010-11-01 |
Gruenenthal Gmbh |
Substituted spiro-amide compounds
|
US8329907B2
(en)
|
2009-04-02 |
2012-12-11 |
Merck Patent Gmbh |
Autotaxin inhibitors
|
ES2527788T3
(es)
|
2009-04-02 |
2015-01-30 |
Merck Patent Gmbh |
Compuestos heterocíclicos como inhibidores de autotaxina
|
JP5591318B2
(ja)
|
2009-04-02 |
2014-09-17 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング |
オートタキシン阻害剤としてのピペリジンおよびピペラジン誘導体
|
FR2945534B1
(fr)
|
2009-05-12 |
2012-11-16 |
Sanofi Aventis |
DERIVES DE CYCLOPENTAL[c]PYRROLE-2-CARBOXYLATES, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
|
US8648066B2
(en)
|
2009-05-22 |
2014-02-11 |
Exelixis, Inc. |
Benzoxazepines as inhibitors of PI3K/mTOR and methods of their use and manufacture
|
WO2010141817A1
(en)
|
2009-06-05 |
2010-12-09 |
Janssen Pharmaceutica Nv |
Heteroaryl-substituted spirocyclic diamine urea modulators of fatty acid amide hydrolase
|
DE102009033392A1
(de)
|
2009-07-16 |
2011-01-20 |
Merck Patent Gmbh |
Heterocyclische Verbindungen als Autotaxin-Inhibitoren II
|
WO2011017350A2
(en)
|
2009-08-04 |
2011-02-10 |
Amira Pharmaceuticals, Inc. |
Compounds as lysophosphatidic acid receptor antagonists
|
UA107360C2
(en)
|
2009-08-05 |
2014-12-25 |
Biogen Idec Inc |
Bicyclic aryl sphingosine 1-phosphate analogs
|
AR079022A1
(es)
|
2009-11-02 |
2011-12-21 |
Sanofi Aventis |
Derivados de acido carboxilico ciclico sustituidos con acilamino, su uso como productos farmaceuticos, composicion farmaceutica y metodo de preparacion
|
KR20120112755A
(ko)
|
2010-01-07 |
2012-10-11 |
이 아이 듀폰 디 네모아 앤드 캄파니 |
살진균제 복소환 화합물
|
US8815869B2
(en)
|
2010-03-18 |
2014-08-26 |
Abbvie Inc. |
Lactam acetamides as calcium channel blockers
|
SG183812A1
(en)
|
2010-03-19 |
2012-10-30 |
Pfizer |
2,3 dihydro-1h-inden-1-yl- 2,7-diazaspiro [3.5] nonane derivatives and their use as antagonists or inverse agonists of the ghrelin receptor
|
US9029387B2
(en)
|
2010-03-26 |
2015-05-12 |
Merck Patent Gmbh |
Benzonaphthyridinamines as autotaxin inhibitors
|
GB201008005D0
(en)
|
2010-05-13 |
2010-06-30 |
Sentinel Oncology Ltd |
Pharmaceutical compounds
|
WO2011151461A2
(en)
|
2010-06-04 |
2011-12-08 |
B.S.R.C. "Alexander Fleming" |
Autotaxin pathway modulation and uses thereof
|
AR082590A1
(es)
|
2010-08-12 |
2012-12-19 |
Hoffmann La Roche |
Inhibidores de la tirosina-quinasa de bruton
|
EP2606031B1
(en)
|
2010-08-20 |
2017-09-27 |
Amira Pharmaceuticals, Inc. |
Autotaxin inhibitors and uses thereof
|
US8859775B2
(en)
|
2010-09-02 |
2014-10-14 |
Merck Patent Gmbh |
Pyrazolopyridinone derivatives as LPA receptor antagonists
|
EP2646428B1
(en)
|
2010-12-02 |
2016-06-01 |
Shanghai De Novo Pharmatech Co Ltd. |
Heterocyclic derivatives, preparation processes and medical uses thereof
|
EP2651405A2
(en)
|
2010-12-14 |
2013-10-23 |
Electrophoretics Limited |
Casein kinase 1 (ck1 ) inhibitors
|
US9260416B2
(en)
|
2011-05-27 |
2016-02-16 |
Amira Pharmaceuticals, Inc. |
Heterocyclic autotaxin inhibitors and uses thereof
|
EP2751118B1
(en)
|
2011-08-29 |
2016-10-12 |
Bristol-Myers Squibb Company |
Spiro bicyclic diamine derivatives as hiv attachment inhibitors
|
WO2013054185A1
(en)
|
2011-10-13 |
2013-04-18 |
Pfizer, Inc. |
Pyrimidine and pyridine derivatives useful in therapy
|
JPWO2013065712A1
(ja)
|
2011-10-31 |
2015-04-02 |
東レ株式会社 |
ジアザスピロウレア誘導体及びその医薬用途
|
US8809552B2
(en)
|
2011-11-01 |
2014-08-19 |
Hoffmann-La Roche Inc. |
Azetidine compounds, compositions and methods of use
|
CA2856946C
(en)
|
2011-12-02 |
2016-08-02 |
Phenex Pharmaceuticals Ag |
Pyrrolo carboxamides as modulators of orphan nuclear receptor rar-related orphan receptor-gamma (rory, nr1f3) activity and for the treatment of chronic inflammatory and autoimmunediseases
|
TWI638802B
(zh)
|
2012-05-24 |
2018-10-21 |
芬蘭商奧利安公司 |
兒茶酚o-甲基轉移酶活性抑制化合物
|
WO2014007951A2
(en)
|
2012-06-13 |
2014-01-09 |
Incyte Corporation |
Substituted tricyclic compounds as fgfr inhibitors
|
WO2013186159A1
(en)
|
2012-06-13 |
2013-12-19 |
F. Hoffmann-La Roche Ag |
New diazaspirocycloalkane and azaspirocycloalkane
|
CA2871388A1
(en)
|
2012-06-27 |
2014-01-03 |
F. Hoffmann-La Roche Ag |
5-azaindazole compounds and methods of use
|
ES2671194T3
(es)
|
2012-07-27 |
2018-06-05 |
Biogen Ma Inc. |
Compuestos que son agentes moduladores de S1P y/o agentes moduladores de ATX
|
EA028364B1
(ru)
|
2012-07-27 |
2017-11-30 |
Биоген Айдек Ма Инк. |
Аутотаксин-модулирующие соединения
|
AR092211A1
(es)
*
|
2012-09-24 |
2015-04-08 |
Merck Patent Ges Mit Beschränkter Haftung |
Derivados de hidropirrolopirrol
|
ES2687985T3
(es)
|
2012-09-25 |
2018-10-30 |
Bayer Pharma Aktiengesellschaft |
Combinación de regorafenib y ácido acetilsalicílico para el tratamiento del cáncer colorrectal
|
CA2878442A1
(en)
|
2012-09-25 |
2014-04-03 |
F. Hoffmann-La Roche Ag |
Hexahydropyrrolo[3,4-c]pyrrole derivatives and related compounds as autotaxin (atx) inhibitors and as inhibitors of the lysophosphatidic acid (lpa) production for treating e.g. renal diseases
|
AR092742A1
(es)
|
2012-10-02 |
2015-04-29 |
Intermune Inc |
Piridinonas antifibroticas
|
AU2013334236B2
(en)
|
2012-10-25 |
2018-04-05 |
Tetra Discovery Partners, Llc. |
Heteroaryl inhibitors of PDE4
|
NZ708255A
(en)
|
2012-12-31 |
2016-08-26 |
Cadila Healthcare Ltd |
Substituted phthalazin-1 (2h)-one derivatives as selective inhibitors of poly (adp-ribose) polymerase-1
|
JPWO2014133112A1
(ja)
|
2013-03-01 |
2017-02-02 |
国立大学法人 東京大学 |
オートタキシン阻害活性を有する8−置換イミダゾピリミジノン誘導体
|
TWI593692B
(zh)
|
2013-03-12 |
2017-08-01 |
美國禮來大藥廠 |
四氫吡咯并噻嗪化合物
|
EP3539962A1
(en)
|
2013-03-12 |
2019-09-18 |
AbbVie Inc. |
Tetracyclic bromodomain inhibitors
|
AR095079A1
(es)
*
|
2013-03-12 |
2015-09-16 |
Hoffmann La Roche |
Derivados de octahidro-pirrolo[3,4-c]-pirrol y piridina-fenilo
|
US9133154B2
(en)
|
2013-03-12 |
2015-09-15 |
Acucela Inc. |
Substituted 3-phenylpropylamine derivatives for the treatment of ophthalmic diseases and disorders
|
TW201446768A
(zh)
|
2013-03-15 |
2014-12-16 |
Biogen Idec Inc |
S1p及/或atx調節劑
|
EP2991994B1
(en)
|
2013-05-01 |
2018-08-15 |
Vitae Pharmaceuticals, Inc. |
Thiazolopyrrolidine inhibitors of ror-gamma
|
CU24355B1
(es)
|
2013-07-18 |
2018-08-06 |
Novartis Ag |
Derivados de 2((( oxadiazol/triazol/tetrazol/isoxazol) metil) fenil)-1-(heterociclil)-ona como inhibidores activos de autotaxina
|
RS57306B1
(sr)
|
2013-10-17 |
2018-08-31 |
Vertex Pharma |
Inhibitori dnk-pk
|
PE20160654A1
(es)
|
2013-11-22 |
2016-07-15 |
Pharmakea Inc |
Compuestos de inhibidor de autotaxina
|
AR098475A1
(es)
|
2013-11-26 |
2016-06-01 |
Bayer Cropscience Ag |
Compuestos pesticidas y usos
|
PT3074400T
(pt)
|
2013-11-26 |
2018-01-22 |
Hoffmann La Roche |
Novo octahidro-ciclobuta [1,2-c;3,4-c']dipirrol-2-il
|
WO2015144609A1
(en)
|
2014-03-26 |
2015-10-01 |
F. Hoffmann-La Roche Ag |
Condensed [1,4]diazepine compounds as autotaxin (atx) and lysophosphatidic acid (lpa) production inhibitors
|
MA50635A
(fr)
|
2014-03-26 |
2020-08-12 |
Hoffmann La Roche |
Nouveaux composés bicycliques comme inhibiteurs de la production d'autotaxin (atx) et de l'acide lysophosphatidique
|
JO3512B1
(ar)
|
2014-03-26 |
2020-07-05 |
Astex Therapeutics Ltd |
مشتقات كينوكسالين مفيدة كمعدلات لإنزيم fgfr كيناز
|
JP2017515794A
(ja)
|
2014-03-26 |
2017-06-15 |
ビーエーエスエフ ソシエタス・ヨーロピアBasf Se |
殺菌剤としての置換[1,2,4]トリアゾール及びイミダゾール化合物
|
AU2015240519B2
(en)
|
2014-04-04 |
2019-08-15 |
X-Rx, Inc. |
Substituted spirocyclic inhibitors of autotaxin
|
EP3187492A4
(en)
|
2014-08-29 |
2018-05-09 |
The University of Tokyo |
Pyrimidinone derivative having autotaxin-inhibitory activity
|
TWI675032B
(zh)
|
2014-10-14 |
2019-10-21 |
美商維它藥物公司 |
ROR-γ之二氫吡咯并吡啶抑制劑
|
AU2016217851A1
(en)
|
2015-02-15 |
2017-08-03 |
F. Hoffmann-La Roche Ag |
1-(het)arylsulfonyl-(pyrrolidine or piperidine)-2-carboxamide derivatives and their use as TRPA1 antagonists
|
MA41898A
(fr)
|
2015-04-10 |
2018-02-13 |
Hoffmann La Roche |
Dérivés de quinazolinone bicyclique
|
CN104927727B
(zh)
|
2015-07-06 |
2017-01-11 |
香山红叶建设有限公司 |
一种玻璃幕墙用结构密封胶及其制备方法
|
PL415078A1
(pl)
|
2015-09-04 |
2017-03-13 |
Oncoarendi Therapeutics Spółka Z Ograniczoną Odpowiedzialnością |
Podstawione aminotriazole przydatne jako inhibitory kwaśnej chitynazy ssaków
|
MX2020004504A
(es)
|
2015-09-04 |
2021-11-10 |
Hoffmann La Roche |
Derivados de fenoximetilo.
|
KR20180054634A
(ko)
|
2015-09-24 |
2018-05-24 |
에프. 호프만-라 로슈 아게 |
이중 오토탁신(atx)/탄산 무수화효소(ca) 억제제로서 신규한 이환형 화합물
|
BR112018006034A2
(pt)
*
|
2015-09-24 |
2018-10-09 |
Hoffmann La Roche |
compostos bicíclicos como inibidores de atx
|
SG10201913209WA
(en)
|
2015-09-24 |
2020-02-27 |
Ionis Pharmaceuticals Inc |
Modulators of kras expression
|
CA2984585A1
(en)
|
2015-09-24 |
2017-03-30 |
F. Hoffmann-La Roche Ag |
New bicyclic compounds as dual atx/ca inhibitors
|
AU2016328535A1
(en)
|
2015-09-24 |
2017-11-09 |
F. Hoffmann-La Roche Ag |
Bicyclic compounds as ATX inhibitors
|
US10323038B2
(en)
*
|
2015-11-20 |
2019-06-18 |
Abide Therapeutics, Inc. |
Pyrazole compounds and methods of making and using same
|
WO2017087858A1
(en)
*
|
2015-11-20 |
2017-05-26 |
Abide Therapeutics, Inc. |
Pyrazole compounds and methods of making and using same
|
EP3380100A4
(en)
|
2015-11-25 |
2019-10-02 |
Dana-Farber Cancer Institute, Inc. |
BIVALENT BROMODOMAIN INHIBITORS AND USES THEREOF
|
CA3006029C
(en)
|
2015-12-01 |
2020-08-04 |
Nihon Nohyaku Co., Ltd. |
3h-pyrrolopyridine compound, n-oxide thereof or salt thereof, agricultural and horticultural insecticide comprising the compound and method for using the same
|
WO2017139978A1
(zh)
|
2016-02-19 |
2017-08-24 |
吴伟东 |
手机app更新方法及***
|
JP7090099B2
(ja)
|
2017-03-16 |
2022-06-23 |
エフ.ホフマン-ラ ロシュ アーゲー |
Atxインヒビターとしての新規二環式化合物
|
RU2019132254A
(ru)
|
2017-03-16 |
2021-04-16 |
Ф. Хоффманн-Ля Рош Аг |
Гетероциклические соединения, пригодные в качестве дуальных ингибиторов atx/ca
|
RS59306B1
(sr)
|
2017-03-20 |
2019-10-31 |
Forma Therapeutics Inc |
Kompozicije pirolopirola kao aktivatori piruvat kinaze (pkr)
|